The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.


Updates from The Motley Fool

Latest updates on Abiomed from Fool.com.


Stock Performance

ABMD vs. S&P 500 | 2 Year Performance
View Interactive ABMD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Abiomed.
Current Price: $116.25
Prev Close: $116.01
Open: $116.07
Bid: $115.50
Ask: $125.00
Day's Range: $115.07 - $116.47
52wk Range: $67.80 - $119.90
Volume: 435,028
Avg Vol 697,839
Market Cap: $4.93B
P/E (ttm): 136.48
EPS (ttm): $0.85
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Abiomed.
CAPS Rating 4 out of 5
 
170 Outperform
33 Underperform
CAPS All Stars
 
25 Outperform
11 Underperform

How do you think Abiomed will perform against the market?



You pick for Abiomed is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael R. Minogue, CEO

68% Approve

Based on 22 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Abiomed.

The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT